Bachem Holding AG, a technology-based biochemicals company, provides various services to the pharmaceutical and biotechnology industries primarily in Europe and North America. The company is engaged in the process development; and the manufacture of peptides and complex organic molecules as active pharmaceutical ingredients (APIs), as well as biochemicals for research purposes. It offers research products, which include catalog products comprising amino acid derivatives, peptides, non-peptidic biochemicals, immunology products, and other biochemicals in various packaging sizes for peptide research, small scale peptide synthesis, or other research area; Melusine venom libraries, including common venom discovery collections, rare venom discovery collections, rare spider venom collections, and snake venom collections for discovering new drug candidates; sterile peptides under the Clinalfa brand; and custom synthesis service for peptides and amino acids. The company also provides API products, including generic APIs that are used in the fields of cancer, diabetes, obesity, fertility, and others; and new chemical entities. In addition, the company offers customer support services, such as formulation development; sterile tox-vials; compatibility studies; stress tests; post-release stability studies; chemistry, manufacturing, and control documentation for Investigational Medicinal Product Dossier and Investigational New Drug services; and other services. Bachem Holding AG was founded in 1971 and is headquartered in Bubendorf, Switzerland.
bachem holding ag-reg b
(BANB:SIX Swiss Ex)
Phone: 41 61 935 23 23
Fax: 41 61 935 23 25www.bachem.com
|No competitor information is available for BANB.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact BACHEM HOLDING AG-REG B, please visit www.bachem.com. Company data is provided by Capital IQ. Please use this form to report any data issues.